Showing results (1421-1430 of 5,686) with videos related to
Sort By:
Pageof 569
Drug Design, Development and Therapy|October 10, 2015
Ghrelin reduces liver impairment in a model of concanavalin A-induced acute hepatitis in miceYuqing Mao, Jianbo Wang, Fujun Yu, et al.Drug Design, Development and Therapy|October 10, 2015
Intravitreal anti-VEGF injections for treating wet age-related macular degeneration: a systematic review and meta-analysisJun Ba, Run-Sheng Peng, Ding Xu, et al.Drug Design, Development and Therapy|October 29, 2015
Pain relief and improved physical function in knee osteoarthritis patients receiving ongoing hylan G-F 20, a high-molecular-weight hyaluronan, versus other treatment options: data from a large real-world longitudinal cohort in CanadaRobert J Petrella, Craig WakefordDrug Design, Development and Therapy|November 7, 2015
Antibacterial activity and therapeutic efficacy of Fl-P(R)P(R)P(L)-5, a cationic amphiphilic polyproline helix, in a mouse model of staphylococcal skin infectionShankar Thangamani, Manish Nepal, Jean Chmielewski, et al.Drug Design, Development and Therapy|June 23, 2016
Anti-inflammatory effects of guggulsterone on murine macrophage by inhibiting LPS-induced inflammatory cytokines in NF-κB signaling pathwayJin-Hua Zhang, Zhao-Shui Shangguan, Chao Chen, et al.Drug Design, Development and Therapy|June 11, 2016
Computer-aided vaccine designing approach against fish pathogens Edwardsiella tarda and Flavobacterium columnare using bioinformatics softwaresRadha Mahendran, Suganya Jeyabaskar, Gayathri Sitharaman, et al.Drug Design, Development and Therapy|June 17, 2016
Evaluation of wound healing properties of bioactive aqueous fraction from Moringa oleifera Lam on experimentally induced diabetic animal modelAbubakar Amali Muhammad, Palanisamy Arulselvan, Pike See Cheah, et al.Drug Design, Development and Therapy|June 17, 2016
Sulfasalazine inhibits inflammation and fibrogenesis in pancreas via NF-κB signaling pathway in rats with oxidative stress-induced pancreatic injuryYa-Ru Wang, Fei-Long Tian, Ming-Xian Yan, et al.Drug Design, Development and Therapy|June 17, 2016
An open-label clinical trial of agalsidase alfa enzyme replacement therapy in children with Fabry disease who are naïve to enzyme replacement therapyOzlem Goker-Alpan, Nicola Longo, Marie McDonald, et al.Drug Design, Development and Therapy|June 18, 2016
Synthesis, activity, and docking study of phenylthiazole acids as potential agonists of PPARγLiang Ma, Taijin Wang, Min Shi, et al.Pageof 569